![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SWEDISH STUDY FINDINGS COULD LEAD TO MALARIA VACCINE
SWEDISH STUDY FINDINGS COULD LEAD TO MALARIA VACCINE
September 6, 2006
A joint study between Karolinska Institutet in Sweden and Makerere University in Uganda has produced important findings on how the malaria parasite conceals itself in the placenta.
Plasmodium falciparium, the most severe form of malaria, hits pregnant women and their unborn children the hardest. This infection can lead to serous complications, including death of the mother during delivery.
The study results, which are published in the American journal The Proceedings of the National Academy of Sciences, could enable the development of a malaria vaccine, according to researchers.
During one phase of its lifecycle, the
malaria parasite enters red blood cells, where it produces proteins that attach
themselves to receptors in the wall of the blood vessels. This causes the red
blood cells to accumulate in organ capillaries, and gives rise to life-threatening
symptoms. Adults who have been infected several times can become partly immune.
When the placenta is formed, however, a new environment is introduced, meaning
a new growth niche is made available to a subpopulation of parasites.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct